Out of the Blue: An AJRCCM Podcast

エピソード

• Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis 28.05.2026 33分

  Dr. Mohleen Kang speaks with Dr. Chris Ryerson, Dr. Johannson, and Dr. Fernández Pérez about their papers, "Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography" and "Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia."
• The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis 14.05.2026 34分

  Dr. John Fleetham speaks with Dr. Leonardo Martinez about his article, "The Effectiveness of Isoniazid Preventive Treatment Among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis."
• Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3) 30.04.2026 35分

  Dr. Michael Lanspa chats with Dr. Ewan Goligher about his article, "Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)."
• Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease 23.04.2026 46分

  Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, "Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease."
• Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline 26.03.2026 16分

  Dr. John Fleetham chats with Dr. Sonal Munsiff and Dr. Raquel Duarte about their article, "Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline." 
• “Social Apnea”: Obstructive Sleep Apnea Is Exacerbated on Weekends 26.02.2026 22分

  Dr. John Fleetham chats with Danny Eckert about his article, "Obstructive Sleep Apnea is Exacerbated on Weekends."
• A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis and One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease 19.02.2026 48分

  Dr. Mohleen Kang chats with Dr. Stephen Humphries, Dr. Matthew Koslow, Dr. Justin Oldham, Dr. Jennifer Wang, Alexander Bankier, and Dr. David Baraghoshi about their articles, "A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis" and "One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease."
• Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis 05.02.2026 30分

  Dr. Michael Lanspa chats with Dr. Natasha Spottiswoode and Chaz Langelier about their article, "Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis."
• Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation and Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids 29.01.2026 25分

  Dr. John Fleetham chats with Dr. Barbro N Melgert and Dr. Chris Carlsten about their articles, "Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation" and "Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids."
• Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial 27.11.2025 17分

  Dr Michael Lanspa chats with Dr. Imeen van der Wal and Dr. Chloe Grim on their article, "Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial." 
• Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline 13.11.2025 30分

  Dr. John Fleetham chats with Dr. Barbara Jones about her ATS guideline, "Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline."
• Is CT Screening For Lung Cancer Generalizable to Older Patients? 06.11.2025 38分

  In this podcast, we review a comparison of outcomes in patients 65-74 years old from SEER-Medicare and NLST datasets in stage I lung cancer with study first author, Dr. Nichole Tanner as well as Dr. Neal Navani.
• Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis 09.10.2025 33分

  Dr. Mohleen Kang chats with Dr. Chris Ryerson, Dr. Johannson, and Dr. Fernández Pérez about their papers, "Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography" and "Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonitis: Unveiling Bronchiolocentric Patterns of Interstitial Pneumonia."
• Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3) 11.09.2025 35分

  Dr. Michael Lanspa chats with Dr. Ewan Goligher about his article, "Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)."
• Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis 04.09.2025 21分

  Dr. Mohleen Kang chats with Dr. Justin Oldham, Dr. Chad Newton and Dr. Jesse Roman about their papers, "Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis" and "Progress in Progressive Pulmonary Fibrosis."
• A New Global Definition of Acute Respiratory Distress Syndrome 28.08.2025 33分

  Dr. Michael Lanspa chats with Dr. Michael Matthay about his article, "A New Global Definition of Acute Respiratory Distress Syndrome."
• Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease 21.08.2025 21分

  Dr. John Fleetham chats with Dr. Chris Ryerson and Dr. Yet Khor about their article, "Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease."
• Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease 31.07.2025 46分

  Dr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, "Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease."
• Approach to the Evaluation and Management of Interstitial Lung Abnormalities 17.07.2025 30分

  Dr. Mohleen Kang chats with Dr. Anna Podolanczuk and Dr. Gary Hunninghake about their article, "Approach to the Evaluation and Management of Interstitial Lung Abnormalities."
• Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough? 10.07.2025 28分

  Dr. John Fleetham chats with Dr. Jaclyn Smith and Dr. Imran Satia about their articles, "Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?"